If postoperative steroid nasal spraying, patients in the dominant group of eosinophils have the same improvement in quality of life through functional symptoms (95.73%) and the state of the nasal mucosa by endoscopic comments (94, 91%) with those of the dominant non-eosinophilic group (95.48% and 91.84%).